CSS LLC’s Vir Biotechnology VIR Stock Holding History

CSS LLC’s Portfolio VIR Stock Details VIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-3,400	Closed	-$117K	–	955
2020 Q3	$117K	Buy	+3,400	New	+$146K	0.01%	645

Other funds holding VIR

SIAU

SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

APF

Alaska Permanent Fund Juneau, Alaska $1.51B AUM 22.23% 1-Year Est. Return

Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

CSS LLC's VIR Position: Q2 2021 in Review

CSS LLC sold out of Vir Biotechnology (VIR) in Q2 2021, closing a stake of 500 shares — an estimated $26K sold.

CSS LLC first reported a position in VIR in Q3 2020 and held it in 2 quarters. The position peaked at $47K in Q3 2020. 166 funds tracked by Wall St. Rank hold VIR as of Q2 2021.

CSS LLC reported no remaining Vir Biotechnology position as of Q2 2021 after selling out during the quarter.
CSS LLC sold 500 Vir Biotechnology shares in Q2 2021, an estimated $26K.
CSS LLC first reported a position in Vir Biotechnology in Q3 2020 and held it in 2 quarters.
CSS LLC's Vir Biotechnology position peaked at $47K in Q3 2020.
166 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2021.

Based on CSS LLC's 13F filing for Q2 2021, filed 16 Aug 2021.